Iobitridol

Iobitridol stands as a vital nonionic contrast medium utilized in the field of radiological imaging, particularly in X-ray procedures. The molecule's efficiency and utility are attributable to its three iodine atoms, which make up 45.6% of its molecular mass.

Chemical Composition and Properties[edit | edit source]

At the core of Iobitridol's efficacy is its inherent molecular structure, fortified by the presence of three iodine atoms. These iodine atoms contribute to a significant portion of its molecular weight, accounting for almost half at 45.6%^[1]. The nonionic nature of Iobitridol is contrasted by its water solubility, achieved through several hydroxyl (-OH) groups.

Commercial Formulations[edit | edit source]

One of the prominent commercial solutions containing Iobitridol is Xenetix 300, a product of Guerbet based in Roissy, France. This formulation offers Iobitridol at a concentration of 300 mg iodine/ml. The recommended dosage for optimal efficacy spans from 1.1 to 2.8 ml/kg of body mass, which translates to an iodine concentration of 0.33 to 0.84 g/kg within the human body^[2].

Applications and Metabolism[edit | edit source]

Upon intravenous administration, Iobitridol undergoes renal filtration, ensuring its prompt and efficient elimination from the human system. Beyond X-ray imaging, its applications are diverse:

Arthrography: Iobitridol aids in the visualization of joint spaces.
Hysterosalpingography: The contrast agent is utilized to fill and delineate the uterus and fallopian tubes, assisting in the evaluation of potential pathologies or anatomical anomalies.

Its pharmacokinetic properties are optimized for safety, minimizing the risk of potential adverse reactions.

Conclusion[edit | edit source]

Iobitridol has carved out a significant niche in the realm of radiological imaging, offering enhanced visualization across a range of diagnostic procedures. With its unique balance of nonionic yet water-soluble properties, and its optimized commercial formulations, it stands as a testament to the advances in contrast media technology.

References[edit | edit source]

Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. British Journal of Radiology, 76(908), 513-518.
Spinazzi, A., Lorusso, V., Pirovano, G., & Taroni, P. (2002). Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Academic Radiology, 9, S305-S313.

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

↑ Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. British Journal of Radiology, 76(908), 513-518.
↑ Spinazzi, A., Lorusso, V., Pirovano, G., & Taroni, P. (2002). Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Academic Radiology, 9, S305-S313.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

[1] Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. British Journal of Radiology, 76(908), 513-518.

[2] Spinazzi, A., Lorusso, V., Pirovano, G., & Taroni, P. (2002). Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Academic Radiology, 9, S305-S313.

[1]

[2]